Article

eAbstract: Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing's Syndrome

This study determined that posterior retroperitoneoscopic adrenalectomy is a safe procedure for patients with Cushing's syndrome.

Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing’s Syndrome

Journal: World Journal of Surgery (February 2010)

Authors: Alesina PF, Hommeltenberg S, Meier B, et al.

Purpose: To examine the safety and efficacy of posterior retroperitoneoscopic adrenalectomy in patients with Cushing’s syndrome.

Results: The mortality rate for the procedures was zero, and no complications occurred. The researchers concluded that “the posterior retroperitoneoscopic approach is fast and safe even in patients with Cushing’s syndrome.”

Click here to access this third-party resource.

Related Videos
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Rahul Aggarwal, MD | Credit: LinkedIn
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
© 2024 MJH Life Sciences

All rights reserved.